Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin in Advanced Ovarian Cancer
NCT00003560Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- May 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), uterine papillary serous carcinoma (UPSC), sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
docetaxel
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)uterine papillary serous carcinoma (UPSC)
Beyond the preview
Go deeper on NCT00003560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003560.